A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Clinical trial NCT02384382 · COMPLETED
Trial details
- NCT number
- NCT02384382
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2019-05-03
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.